and apparent volume of distribution (ranging between 63 and 1770 ml min 21 , and 48.3 and 417.5 litre, respectively).
In the present study, CoMFA has been used to determine those molecular features that may help define their clearance and apparent volume of distribution. As haemodynamic consequences of anaesthesia may influence drug kinetics, the resulting CoMFA models have then been compared with our previous models for cardiovascular depression, 4 and also with some physicochemical variables [log P (octanolwater partition coefficient), molecular weight, and free drug fraction].
Methods
The same group of 14 structurally diverse i.v. anaesthetic hypnotic agents used in previous studies were considered [eltanolone, alphaxalone, minaxolone, ORG 21465, thiamylal, thiopental, methohexital, pentobarbital, S(+)-and R(2)-ketamine, R-etomidate, clomethiazole, propofol, ORG 25435]. 6 -20 Two kinetic parameters were studied: systemic clearance and apparent volume of distribution at steady state (Tables 1 and 2 ). Where available, these kinetic data were taken from bolus dose studies in adult patients with no co-morbidities in order to provide comparable estimates for the two parameters. Where several sets of data were identified, studies with median parameter values were chosen for use in this analysis. Data are shown as corrected values based on the mean weight of the study population. Data for plasma protein binding (PPB) and octanol -water partition coefficient (log P) were taken from the literature or from unpublished studies (as cited in Sewell and Sear). 1 Data used for the models of cardiovascular depression and immobilization were those previously published in Sewell and Sear 1 and Sear. 4 
Modelling
This has been extensively described previously, 1 but is partly repeated here for clarity. The same approach based on fieldfit alignment was used for both disposition kinetic models and the models of cardiovascular depression and immobilizing activity. 1 4 Anaesthetic structures were formulated using the molecular modelling software SYBYL v7.3 (Tripos Inc., St Louis, MI, USA) on a Silicon Graphics O2 R10000 workstation, with the compounds modelled in their unionized state. 1 The starting structures were geometry optimized using molecular mechanics optimization to define the structures with the minimum total potential energy. The default Tripos molecular force field was used as implemented in SYBYL v7.3. In this approach, the Gasteiger-Huckel partial charges were assigned to each atom, and non-bonded electrostatic interactions calculated using a distance-dependent dielectric function. The latter simulates the electrostatic screening effect of the solvent without explicitly including the solvent molecules in the calculation. For each anaesthetic, a set of low energy conformers were identified by a random search procedure in SYBYL. Only those given anaesthetic were retained and considered further.
Since the probability of a specific conformer occurring is related to the potential energy of the structure, the applied limit ensured that only realistic molecular configurations of the anaesthetics were considered. The process was repeated until each anaesthetic had been subjected to 10 000 random structure perturbations or until each of the low energy conformers had been found at least 12 times. The geometries of the compounds were further refined using quantum mechanics. A mathematical model of molecular structure was formed in terms of the nuclei and electron distributions, so providing a more accurate representation of molecular geometry. This modelling was carried out using the MOPAC 6 software package (Quantum Chemistry Program Exchange, IN, USA) with the AM1 Hamiltonian, and atomic partial charges assigned using the Coulsdon method. After geometry optimization, duplicate conformers (defined as conformers with an RMS difference of ,0.2 Å ) were removed. The final set of molecular structures consisted of 1176 unique conformers for the 14 anaesthetics.
Structure alignment
Because the chemical diversity of the i.v. agents precluded adequate alignment by a common substructure, the low energy conformers were aligned to the lead structure for CoMFA by field-fit minimization. 21 22 The same lead structure, eltanolone (the most potent agent with regard to immobilization), was used as in previous studies.
1 4 5 CoMFA formulation
Separate CoMFA models for electrostatic and steric features were derived for each pharmacokinetic parameter. The aligned structures were placed in a grid consisting of lattice points at 1 Å intervals. An sp3 carbon atom with a charge of +1.0 was used as a probe to generate the steric and electrostatic interaction energies between the probe and the anaesthetic molecules at each lattice point. Steric energies were calculated using a Leonard -Jones 6-12 potential, which describes the attraction between molecules due to van der Waals forces (dispersion, dipole-induced dipole, and dipole -dipole interactions) and the repulsion due to steric clashes. Electrostatic interaction energies were calculated using Coulomb potentials with a distance-dependent dielectric function. A default cut-off value of 30 kcal mol 21 was applied to both steric and electrostatic energies. The orientations of the anaesthetics yielding CoMFA models with the greatest predictive capability were retained. The use of 1 Å grid intervals represented a compromise between accuracy and the introduction of 'noise' from sampling irrelevant data. The grid extended at least 4 Å beyond the surface of the molecules and consisted of 9025 lattice points. The interaction energies at each point were correlated with the individual agents' kinetic parameters using partial least squares regression to formulate the two activity models. These were then compared with those CoMFA models previously described for immobilization and cardiovascular depression. 1 4 
Activity model formation
This was carried out using partial least squares regression analysis to correlate the interaction energies at each lattice CoMFA to derive pharmacophore maps point with the systemic clearance or apparent volumes of distribution at steady state for each agent. 23 Two approaches were used to determine the intrinsic predictive power of the CoMFA models. First, the models were assessed using partial least squares regression to derive leave-one-out cross-validation. 24 In this process, activity models were repeatedly reformulated by leaving one compound out of the model at each stage. The model with the greatest cross-validated r 2 (q 2 ) was retained as the final model. The activity models were further assessed using cross-validation studies with four compounds randomly excluded at each stage. These cross-validation studies were each run for 10 cycles, and the mean (SD) values ( mCV4q 2 ) were calculated. For each molecule, the interaction energies were correlated with the kinetic parameter using partial least squares regression analysis.
For the physicochemical models, linear regression was used to compare the three variables with observed values for Cl s and Vd ss .
Results
The final CoMFA models for both systemic clearance (Cl s ) and apparent volume of distribution at steady state (Vd ss ) were based on two latent variables. Tables 1 and 2) . Conventional physicochemical models based on log P (the octanol-water partition coefficient) showed poorer associations for Cl s (r¼0.507; P¼0.08) but not for Vd ss (r¼ 20.153; NS) explaining 25.7% and 2.3% of the observed variances. There was an association between log P and the free drug fraction (r¼0.753; P,0.01). There were also associations between log P and the unbound (free) drug kinetic parameters Cl s u and Vd ss u (r values of 0.769 and 20.700 respectively; both P,0.01). There was also a relationship between molecular weight and free drug fraction (r¼0.462; P¼0.09) and Vd ss (r¼ 20.669; P,0.01).
Comparison of pharmacophores
The pharmacophore maps for clearance and volume of distribution show distinct positive (blue) and negative (red) charged areas, and bulk-favoured (green) and bulkdisfavoured (magenta) areas. The underlying chemical steroid in the figures is that of the most potent agent for immobilization (eltanolone-5b pregnanolone). The location of steric and electrostatic features of the pharmacophores is described with respect to the structure of this 5b pregnane.
Apart from differences in the relative contributions that steric and electrostatic interactions make to the overall CoMFA activity models, the electrostatic component was larger for both kinetic pharmacophores. The relative contributions of electrostatic and steric interactions to the models were 65.9%:34.1% for Cl s ; and 73.7%:26.3% for Vd ss (1.9:1 and 2.5:1).
Commonalities
The electrostatic pharmacophoric map for clearance shows three distinct positive areas and two separate negative areas, the one adjacent to the B ring of the steroid being smaller. In contrast, the map for the apparent volume of distribution has two main positive areas which are contiguous one with the other, and one large negatively charged area lying above and below the plane of the 5b-pregnanolone molecule. There are two smaller positive-charged areas related to the B ring and C/D ring interface.
The steric maps show a greater degree of similarity between the kinetic pharmacophores with three bulkfavoured (green) areas in each pharmacophore, and three disfavoured areas. The magnitude of the favoured areas is greater for clearance, while the disfavoured areas represent a greater area for the volume model.
There are key regions within each model, but comparison using isocontour correlations (based on contours drawn linking lattice points making the greatest 40% of the individual positive or negative contributions for each model) shows poor correlations between models (r¼20.220 for electrostatic and 0.018 for steric energies, both NS).
Inspection of the pharmacophores (Fig. 1A -D) shows there to be only three regions where there is any real commonality between the maps for clearance and apparent volume of distribution. The electrostatic models show a common positivecharged area adjacent to the C ring of the steroid structure. The steric models show a bulk-disfavoured region approximate to the A ring of the steroid structure of eltanolone; and a bulk-favoured region adjacent to the B ring.
Comparison with the cardiovascular depression and immobilization pharmacophores
Since drug distribution and clearance for i.v. agents are partly dependent on tissue and liver blood flows, respectively, comparison has been made with previously published model data for cardiovascular depression (measured as the free drug concentration associated with a 20% decrease in mean arterial pressure during maintenance anaesthesia) ( Fig. 2A  and B) . 4 The latter model was based on a single latent vari- 
Discussion
This study shows that CoMFA models can be formulated which accurately predict the systemic clearance and volume of distribution at steady state in terms of the threedimensional spatial distribution of electrostatic and static regions. Other studies have focused on the relationships between kinetic properties and the physicochemical features of individual agents, but few have used the technique of CoMFA.
Proost and colleagues 25 examined the relationship between some physicochemical parameters and their corresponding pharmacokinetics for a series of amino-steroid neuromuscular blocking drugs. They found a positive correlation between log P (octanol:Krebs partition coefficient) and PPB, and a negative correlation with the elimination halflife, mean residence time, and volume of distribution, but no relationship with clearance. However, when unbound values for clearance and volume of distribution were correlated with log P, the results showed significant positive and negative relationships. There was therefore an increase in unbound plasma clearance with increasing lipophilicity. In a separate study, again involving neuromuscular blocking drugs, Roy and Varin 26 found a significant association between log D (the octanol-phosphate buffer partition coefficient) and lipid solubility. Furthermore, these two parameters plus free drug fraction were significantly associated with two properties of the kinetics of drug responsenamely EC 50 (potency) and k e0 (the rate of equilibration between the blood and the effect-site concentration).
The data in the present study, which comprises a chemically heterogeneous collection of i.v. anaesthetic agents, show similar associations with log P significantly correlated with free fraction, and plasma clearance. Log P is also significantly associated with free drug clearance, and negatively correlated with the free drug volume of distribution at steady state. The other physicochemical correlations include a negative relationship between molecular weight and the apparent volume of distribution at steady state. Fig 1 (A-D) Electrostatic and steric pharmacophores for systemic clearance and apparent volume of distribution at steady state for 14 i.v. hypnotic agents. Data were taken, where possible, from studies where the agent has been given as a bolus dose. The electrostatic potential pharmacophoric maps show spatial distribution where negative (red) and positive (blue) areas are favoured for high clearance or volume of distribution. Steric pharmacophoric maps show the spatial distribution of regions where molecular bulk is favoured (green) or disfavoured (magenta) for high clearance or volume of distribution. Apart from differences in the relative contributions that steric and electrostatic interactions make to the overall CoMFA activity models, the electrostatic component was larger for both kinetic pharmacophores. There are several key regions within each model, but comparison between models shows poor isocontour correlations. Inspection shows three regions where there is any real commonality-a bulk-disfavoured region approximate to the A ring of the steroid structure of the lead compound eltanolone; a bulk-favoured region adjacent to the B ring; and a positive-charged area adjacent to the C ring.
The CoMFA models for both clearance and volume of distribution show high q 2 and mCV4q 2 values, coupled with low absolute log residuals, indicating a robustness of the models. There are some values which fall outside two standard deviations from the mean (pentobarbital and thiopental in the case of clearance and thiopental, eltanolone and alphaxalone for the apparent volume of distribution). However, this may reflex poor characterization of the drugs' kinetic estimates and the paucity of data sets included in the models. In a previous publication, 4 we used an alternative approach for assessing the robustness of the derived CoMFA models. The data set was divided into a training set of 10 randomly selected compounds, with the remaining four making up the test set data (the only constraint being nomination of the lead compound into the training set). There is no real difference between the q 2 values achieved with that approach and the all-in field-fit minimization technique used here for immobilizing activity (q 2 values of 0.768 and 0.882, respectively). Additional assessment of robustness here has been through determination of the mCV4q 2 mean, SD, and range.
In this approach, four compounds are randomly excluded, with the resulting q 2 ranges being 0.367 -0.628 for log clearance and 0.520 -0.742 for log Vd ss .
There is little similarity between the pharmacophores (both electrostatic and steric) for clearance and apparent volume of distribution, but both show some similarity with the pharmacophores for cardiovascular depression.
There are four other published studies where the relationships between quantitative structure and pharmacokinetic properties have been examined. In the first of the studies using molecular descriptor techniques, Van der Graaf and colleagues 27 used CoMFA analysis to describe a total of 16 molecular variables for a series of adenosine A1 receptor agonists. Multivariate regression using partial least squares was used to predict clearance, apparent volume of distribution, and free unbound drug fraction. High r 2 values were obtained: 0.82, 0.61, and 0.78, respectively. The greatest difference between the predicted and observed values was for the apparent volume of distribution; the best predictor for the latter being log P (r¼0.80).
Van der Graaf and colleagues also found a number of significant correlations with other molecular propertiesnamely between HEFO (heat of formation) and clearance, volume of distribution, and the free drug fraction. Clearance also correlated with the 3DPP1 (three-dimensional principal property) and IOPO (ionization potential), while the free fraction showed significant correlation with 3DPP1, IOPO, POP1 (volume of electrostatic potential surface plus one), ELEN (the electronic energy), FILE (filled levels), COAR (area enclosed by Connelly surface), COVO (volume enclosed by the Connelly surface), and COCO (the core -core repulsion). Again, the volume of distribution correlated with log P, as did protein binding.
Other attempts at using molecular modelling for drug kinetics include the experiments of Wolohan and Clark, 28 who modelled molecular interaction fields coupled with soft independent modelling of class analogy to predict human intestinal absorption, blood-brain barrier penetration, and bioavailability of large sets of heterologous compounds.
Similar approaches for the prediction of drug kinetics have also been reported. 29 Using a data set of a heterogeneous series of 70 drugs, a quantitative structure-activity relationship (QSAR) was developed for the prediction of the apparent volume of distribution (Vd). 29 The relationship of many computed, and some experimental, structural descriptors with Vd, and the Vd corrected for protein binding (unbound Vd), was investigated. 29 The models for Vd yielded lower prediction errors than those constructed for the unbound Vd (mean fold error of 2.01 for Vd compared with 2.28 for unbound Vd), while separation of the compounds into acids and bases did not reduce the prediction error significantly. In a second study, a QSPR model was developed by the same group that was able to predict the volume of distribution of 129 drugs belonging to different chemical classes. This had a prediction error similar to that of the other more complicated prediction methods, including the commonly practiced interspecies scaling. 30 Our previous studies have shown a relationship between immobilizing ability and cardiovascular depression both in terms of the blood drug concentration associated with a 20% depression of mean arterial blood pressure, and the decrease in mean arterial blood pressure at the EC 50 drug concentration. 4 Commonality observed in this study between the pharmacophores for cardiovascular depression and the two pharmacophores for the disposition parameters may be partly explained through the role of cardiac output in the distribution and the systemic clearance of drug. The poorer correlations between the pharmacophores for immobilization (a centrally mediated effect for i.v. agents) and those of the two disposition parameters do not suggest that central drug effects play a significant role in drug disposition.
The robustness of the present two kinetic CoMFA models and their associated pharmacophore maps will be tested further by the inclusion of the future data sets for other i.v. anaesthetic agents. Whether this approach for predicting drug kinetics in humans is more reliable than allometric analysis using data from animal species remains unknown. 31 32 
